Legacy iCROs bolted on technology. GenPhase built around it — delivering a truly integrated platform.
ONIX AI is the environment the read happens in, not an analysis layer bolted onto someone else's viewer. That is why analytics arrive inside the read output rather than as a separate deliverable weeks later.
US daytime reads hand off to India overnight reads on the same platform, under the same protocols and audit trail — a genuine follow-the-sun handoff, not two disconnected operations.
Nationally registered radiologists in every reading location, credentialed through the same GCP training and study-specific qualification process regardless of geography.
Quality AssuredGenPhase maintains direct relationships with its reading network under one set of protocols, SLAs, and audit trail requirements — full accountability, consistent service, and direct quality oversight.
Direct OwnershipEvery read is signed by a credentialed subspecialty radiologist inside a 21 CFR Part 11 audit trail — the same governance layer on every case, in every reading location.
Part 11 Audit TrailONIX AI integrates with hospital PACS, eCRF systems, and third-party algorithms via standard APIs.Unlike closed platforms that can create dependency and switching costs, ONIX is designed to support flexibility and interoperability.
PACS — Imaging
Works with any imaging archive
Connects to DICOM-compliant systems from any vendor. No rip-and-replace required - your existing PACS stays in place.
eCRF — Clinical data
Plugs into any trial platform
Bidirectional sync via RESTful and HL7 FHIR endpoints with your existing clinical data capture system.
Algorithms — Models
Run any vendor algorithm
Bring third-party or proprietary models into a unified, validated imaging pipeline - side by side, without conflict.
If you already have imaging infrastructure in place, we integrate with it, not replace it.
Unlike proprietary closed platforms that create dependency and switching costs, GenPhase never locks a sponsor in. Bring your stack - we integrate with it.
GenPhase operates real clinical workflows on its own platform. Every production decision is validated against actual trial workflows from day one - not retrofitted from a staging environment.
"The platform is its own QA."
Scoped and priced for early-phase trials, not built around the assumption of a large registrational study.
Early PhaseA bounded question — eligibility, one endpoint, one cohort — sized as its own engagement rather than folded into a larger program.
Bounded ScopeImaging providers built around large registrational studies are often uneconomic for exactly this work — it is what we are sized for.
Right-SizedModern oncology trials increasingly require both imaging reads (CT/MRI for RECIST) and digital pathology analysis (H&E, IHC).These capabilities are often delivered through separate vendors, adding operational complexity.
GenPhase is building toward a unified, multi-modal platform that brings radiology and pathology together under a single accountable system.
CT/MRI for RECIST compliance. Tumor measurement and oncology response assessment at scale.
H&E and IHC tissue analysis for endpoints.
Oncology under one accountable platform. From scan to slide.
Our clinical and technical team will walk you through how GenPhase compares to your current imaging setup - and what the transition looks like.
1990 N California Blvd., 8th Floor
Walnut Creek, CA 94596
(844) 922-7468
hello@genphase.ai
Fill out the form and our team will reach out within 24 hours to schedule your call.
By submitting this form, you agree to let GenPhase use the information provided to send relevant content about our services. You can unsubscribe at any time.
